Atlas Trials

First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Clinical trial NCT01097746 · COMPLETED

Trial details

NCT number
NCT01097746
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fallopian Tube CarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Serous AdenocarcinomaFallopian Tube Transitional Cell CarcinomaFallopian Tube Undifferentiated CarcinomaFIGO Stage III Ovarian CancerFIGO Stage IIIA Ovarian CancerFIGO Stage IIIA1 Ovarian CancerFIGO Stage IIIA1(i) Ovarian CancerFIGO Stage IIIA1(ii) Ovarian Cancer
Start date
2010-04-14
Primary completion
2021-12-07
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.